HOROWITZ ZEBULUN D 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 19, 2009
Insider Transaction Report
Form 4
HOROWITZ ZEBULUN D
SVP - Chief Medical Officer
Transactions
- Sale
Common Stock, $.01 par value per share
2009-02-17$5.87/sh−5,380$31,555→ 144,683 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2009-02-19$5.27/sh−50,000$263,500→ 50,000 totalExercise: $5.27From: 2010-02-19Exp: 2019-02-19→ Common Stock, $.01 par value per share (50,000 underlying)
Footnotes (2)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
- [F2]These options will become exercisable as to 25% on each of 2/19/10, 2/19/11, 2/19/12 and 2/19/13, provided the optionee remains employed by the Company on these dates.